Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malnutrition | 55 | 2024 | 218 | 13.860 |
Why?
|
Growth Disorders | 31 | 2021 | 218 | 8.160 |
Why?
|
Child Nutrition Disorders | 33 | 2021 | 77 | 7.750 |
Why?
|
Malawi | 88 | 2021 | 378 | 5.680 |
Why?
|
Food, Fortified | 31 | 2023 | 95 | 5.550 |
Why?
|
Dietary Supplements | 37 | 2021 | 558 | 5.290 |
Why?
|
Severe Acute Malnutrition | 14 | 2023 | 23 | 5.170 |
Why?
|
Rural Population | 37 | 2023 | 281 | 4.710 |
Why?
|
Nutritional Status | 27 | 2023 | 337 | 4.560 |
Why?
|
Infant Nutritional Physiological Phenomena | 26 | 2022 | 182 | 3.830 |
Why?
|
Dietary Proteins | 14 | 2019 | 241 | 3.490 |
Why?
|
Intestinal Diseases | 11 | 2021 | 121 | 3.430 |
Why?
|
Diet | 21 | 2021 | 1440 | 3.350 |
Why?
|
Weight Gain | 27 | 2020 | 464 | 3.230 |
Why?
|
Food, Formulated | 12 | 2021 | 50 | 3.180 |
Why?
|
Infant | 117 | 2023 | 13310 | 3.180 |
Why?
|
Zea mays | 20 | 2021 | 46 | 3.050 |
Why?
|
Fabaceae | 6 | 2024 | 26 | 2.840 |
Why?
|
Protein-Energy Malnutrition | 11 | 2022 | 73 | 2.650 |
Why?
|
Feces | 24 | 2023 | 770 | 2.620 |
Why?
|
Child Nutritional Physiological Phenomena | 16 | 2018 | 174 | 2.610 |
Why?
|
Body Height | 16 | 2020 | 231 | 2.590 |
Why?
|
Fast Foods | 10 | 2023 | 31 | 2.560 |
Why?
|
Kwashiorkor | 15 | 2023 | 40 | 2.420 |
Why?
|
Child, Preschool | 99 | 2022 | 16273 | 2.380 |
Why?
|
Zinc | 13 | 2018 | 188 | 2.230 |
Why?
|
Intestinal Mucosa | 11 | 2018 | 1081 | 2.150 |
Why?
|
Infant Nutrition Disorders | 12 | 2021 | 30 | 2.110 |
Why?
|
Malabsorption Syndromes | 6 | 2017 | 55 | 2.100 |
Why?
|
Milk | 9 | 2020 | 120 | 2.040 |
Why?
|
Lactulose | 12 | 2023 | 38 | 2.010 |
Why?
|
Intestinal Absorption | 10 | 2018 | 211 | 1.990 |
Why?
|
Micronutrients | 10 | 2018 | 75 | 1.910 |
Why?
|
Child Development | 17 | 2021 | 255 | 1.890 |
Why?
|
Amoxicillin | 4 | 2016 | 106 | 1.750 |
Why?
|
Vigna | 4 | 2024 | 6 | 1.690 |
Why?
|
Mannitol | 9 | 2018 | 54 | 1.520 |
Why?
|
Home Care Services | 7 | 2019 | 92 | 1.480 |
Why?
|
HIV Wasting Syndrome | 4 | 2010 | 5 | 1.470 |
Why?
|
Food Assistance | 2 | 2021 | 33 | 1.360 |
Why?
|
Amino Acids, Essential | 3 | 2021 | 26 | 1.350 |
Why?
|
Environment | 6 | 2017 | 190 | 1.330 |
Why?
|
Sierra Leone | 11 | 2023 | 28 | 1.300 |
Why?
|
Nutrition Therapy | 3 | 2021 | 21 | 1.260 |
Why?
|
Nutritive Value | 8 | 2018 | 96 | 1.190 |
Why?
|
Plant Oils | 3 | 2020 | 37 | 1.150 |
Why?
|
Humans | 181 | 2024 | 261506 | 1.150 |
Why?
|
Gastrointestinal Microbiome | 8 | 2020 | 907 | 1.140 |
Why?
|
Intestines | 5 | 2020 | 686 | 1.070 |
Why?
|
Manihot | 5 | 2013 | 9 | 1.070 |
Why?
|
Choline | 4 | 2023 | 76 | 1.060 |
Why?
|
Double-Blind Method | 17 | 2020 | 2588 | 1.050 |
Why?
|
Intestine, Small | 6 | 2020 | 499 | 1.040 |
Why?
|
Eggs | 3 | 2021 | 24 | 1.030 |
Why?
|
Anti-Bacterial Agents | 6 | 2021 | 2992 | 0.980 |
Why?
|
Avena | 2 | 2023 | 7 | 0.970 |
Why?
|
Dietary Fats | 8 | 2016 | 339 | 0.970 |
Why?
|
Male | 104 | 2022 | 123000 | 0.960 |
Why?
|
Metabolomics | 4 | 2024 | 478 | 0.950 |
Why?
|
Infant Food | 5 | 2015 | 89 | 0.930 |
Why?
|
Female | 108 | 2024 | 141928 | 0.930 |
Why?
|
Soy Foods | 7 | 2012 | 14 | 0.920 |
Why?
|
Flour | 5 | 2018 | 7 | 0.920 |
Why?
|
Wasting Syndrome | 4 | 2020 | 28 | 0.910 |
Why?
|
RNA, Messenger | 7 | 2021 | 6150 | 0.910 |
Why?
|
Food Analysis | 4 | 2018 | 28 | 0.900 |
Why?
|
Infection Control | 2 | 2022 | 270 | 0.880 |
Why?
|
Cephalosporins | 2 | 2013 | 148 | 0.850 |
Why?
|
Child | 46 | 2024 | 29154 | 0.850 |
Why?
|
Sanitation | 2 | 2019 | 14 | 0.850 |
Why?
|
Enteritis | 3 | 2017 | 65 | 0.840 |
Why?
|
Campylobacter | 4 | 2023 | 25 | 0.840 |
Why?
|
Albendazole | 3 | 2021 | 28 | 0.830 |
Why?
|
Dietary Carbohydrates | 4 | 2019 | 134 | 0.830 |
Why?
|
Amino Acids | 6 | 2024 | 728 | 0.820 |
Why?
|
Cost-Benefit Analysis | 4 | 2021 | 945 | 0.820 |
Why?
|
Cognition | 4 | 2022 | 968 | 0.800 |
Why?
|
Acute Disease | 12 | 2020 | 2422 | 0.800 |
Why?
|
Pregnancy Complications | 3 | 2021 | 526 | 0.790 |
Why?
|
Permeability | 7 | 2021 | 167 | 0.790 |
Why?
|
Microbiota | 3 | 2020 | 547 | 0.780 |
Why?
|
Milk Proteins | 5 | 2020 | 116 | 0.780 |
Why?
|
Colostrum | 1 | 2021 | 49 | 0.780 |
Why?
|
Growth | 5 | 2020 | 117 | 0.780 |
Why?
|
Plant Proteins | 2 | 2020 | 133 | 0.780 |
Why?
|
Infant Mortality | 1 | 2022 | 186 | 0.770 |
Why?
|
Carnitine | 3 | 2024 | 94 | 0.770 |
Why?
|
Diagnostic Tests, Routine | 2 | 2021 | 173 | 0.750 |
Why?
|
Counseling | 3 | 2023 | 381 | 0.750 |
Why?
|
Food Quality | 3 | 2018 | 6 | 0.740 |
Why?
|
Anti-Retroviral Agents | 3 | 2010 | 148 | 0.740 |
Why?
|
Feeding Behavior | 4 | 2017 | 808 | 0.730 |
Why?
|
Nutrition Assessment | 6 | 2016 | 169 | 0.710 |
Why?
|
Phaseolus | 2 | 2017 | 5 | 0.710 |
Why?
|
HIV Infections | 9 | 2015 | 2134 | 0.710 |
Why?
|
Gastrointestinal Diseases | 5 | 2020 | 589 | 0.710 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2017 | 83 | 0.700 |
Why?
|
Food | 6 | 2021 | 146 | 0.680 |
Why?
|
Consumer Behavior | 3 | 2016 | 46 | 0.670 |
Why?
|
Prenatal Care | 1 | 2021 | 325 | 0.670 |
Why?
|
Vitamin A | 3 | 2014 | 94 | 0.670 |
Why?
|
Starch | 2 | 2015 | 47 | 0.650 |
Why?
|
Poverty | 3 | 2020 | 471 | 0.650 |
Why?
|
Phytic Acid | 3 | 2015 | 9 | 0.640 |
Why?
|
Anthropometry | 8 | 2022 | 269 | 0.640 |
Why?
|
Family Characteristics | 2 | 2018 | 102 | 0.640 |
Why?
|
Diarrhea | 5 | 2020 | 686 | 0.640 |
Why?
|
Stomach Diseases | 1 | 2018 | 62 | 0.630 |
Why?
|
Meals | 1 | 2018 | 66 | 0.630 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2017 | 21 | 0.620 |
Why?
|
Iron, Dietary | 2 | 2015 | 19 | 0.620 |
Why?
|
Gastrointestinal Tract | 6 | 2020 | 324 | 0.620 |
Why?
|
Malaria | 4 | 2021 | 92 | 0.610 |
Why?
|
Proteobacteria | 1 | 2016 | 17 | 0.600 |
Why?
|
Eating | 6 | 2019 | 421 | 0.580 |
Why?
|
Schools | 1 | 2018 | 233 | 0.570 |
Why?
|
Betaine | 1 | 2016 | 27 | 0.570 |
Why?
|
Methylamines | 1 | 2016 | 21 | 0.570 |
Why?
|
Jejunal Diseases | 1 | 2016 | 25 | 0.560 |
Why?
|
Duodenitis | 1 | 2016 | 15 | 0.550 |
Why?
|
Serum | 1 | 2016 | 68 | 0.550 |
Why?
|
Programming, Linear | 2 | 2015 | 4 | 0.550 |
Why?
|
Deficiency Diseases | 2 | 2018 | 11 | 0.540 |
Why?
|
Bacteria | 5 | 2020 | 611 | 0.540 |
Why?
|
Maternal-Fetal Exchange | 1 | 2016 | 90 | 0.530 |
Why?
|
International Cooperation | 1 | 2017 | 323 | 0.530 |
Why?
|
Global Health | 3 | 2017 | 657 | 0.530 |
Why?
|
Energy Intake | 9 | 2018 | 515 | 0.530 |
Why?
|
Vulnerable Populations | 1 | 2017 | 167 | 0.520 |
Why?
|
Developing Countries | 7 | 2021 | 315 | 0.520 |
Why?
|
Endotoxins | 1 | 2015 | 96 | 0.520 |
Why?
|
Body Mass Index | 4 | 2010 | 2203 | 0.520 |
Why?
|
Anti-HIV Agents | 4 | 2014 | 350 | 0.510 |
Why?
|
Parity | 1 | 2015 | 139 | 0.500 |
Why?
|
Prospective Studies | 16 | 2023 | 12873 | 0.500 |
Why?
|
Fetal Development | 1 | 2016 | 120 | 0.500 |
Why?
|
Infant, Newborn | 14 | 2023 | 8223 | 0.500 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2023 | 490 | 0.490 |
Why?
|
Arachis | 7 | 2020 | 65 | 0.490 |
Why?
|
Environmental Illness | 1 | 2014 | 2 | 0.490 |
Why?
|
Fetal Growth Retardation | 1 | 2016 | 194 | 0.490 |
Why?
|
Research | 1 | 2017 | 415 | 0.490 |
Why?
|
Treatment Outcome | 31 | 2023 | 32848 | 0.490 |
Why?
|
Protein Deficiency | 2 | 2013 | 20 | 0.480 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 395 | 0.480 |
Why?
|
Ethiopia | 6 | 2023 | 24 | 0.480 |
Why?
|
Fatty Acids | 1 | 2017 | 448 | 0.470 |
Why?
|
Gastrointestinal Agents | 2 | 2014 | 108 | 0.470 |
Why?
|
Inflammation Mediators | 1 | 2016 | 423 | 0.470 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 3203 | 0.460 |
Why?
|
Anemia | 2 | 2019 | 689 | 0.460 |
Why?
|
Nutritional Requirements | 4 | 2017 | 185 | 0.460 |
Why?
|
Edema | 4 | 2009 | 267 | 0.450 |
Why?
|
Body Composition | 2 | 2020 | 595 | 0.450 |
Why?
|
Edible Grain | 3 | 2023 | 54 | 0.440 |
Why?
|
Tandem Mass Spectrometry | 4 | 2022 | 368 | 0.440 |
Why?
|
Gastroenteritis | 1 | 2015 | 300 | 0.440 |
Why?
|
Child Welfare | 2 | 2009 | 66 | 0.420 |
Why?
|
Campylobacter Infections | 2 | 2023 | 36 | 0.420 |
Why?
|
Chromatography, Liquid | 4 | 2017 | 342 | 0.410 |
Why?
|
Antibodies | 1 | 2015 | 838 | 0.410 |
Why?
|
Seeds | 4 | 2017 | 42 | 0.410 |
Why?
|
Food Supply | 5 | 2023 | 97 | 0.400 |
Why?
|
Diarrhea, Infantile | 1 | 2011 | 43 | 0.400 |
Why?
|
Kenya | 5 | 2020 | 46 | 0.390 |
Why?
|
Immunity | 1 | 2013 | 342 | 0.390 |
Why?
|
Community Health Centers | 2 | 2009 | 50 | 0.380 |
Why?
|
Risk Factors | 14 | 2021 | 17523 | 0.380 |
Why?
|
Breast Feeding | 5 | 2021 | 239 | 0.380 |
Why?
|
Biomarkers | 10 | 2024 | 5047 | 0.370 |
Why?
|
Inflammation | 3 | 2021 | 2522 | 0.370 |
Why?
|
Ghana | 3 | 2020 | 14 | 0.370 |
Why?
|
Acute-Phase Reaction | 2 | 2013 | 26 | 0.360 |
Why?
|
Milk, Human | 2 | 2015 | 277 | 0.360 |
Why?
|
India | 3 | 2021 | 301 | 0.360 |
Why?
|
Animals | 25 | 2023 | 59536 | 0.360 |
Why?
|
Whey Proteins | 3 | 2016 | 7 | 0.360 |
Why?
|
Pregnancy | 9 | 2024 | 7573 | 0.350 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 1546 | 0.350 |
Why?
|
Linear Models | 4 | 2015 | 1085 | 0.350 |
Why?
|
Rifamycins | 1 | 2009 | 32 | 0.350 |
Why?
|
Homeostasis | 5 | 2015 | 950 | 0.340 |
Why?
|
Sprue, Tropical | 2 | 2019 | 4 | 0.340 |
Why?
|
Rural Health | 5 | 2017 | 51 | 0.330 |
Why?
|
Fever | 2 | 2011 | 497 | 0.330 |
Why?
|
Hygiene | 2 | 2019 | 24 | 0.330 |
Why?
|
Muramidase | 2 | 2019 | 110 | 0.330 |
Why?
|
Nigeria | 4 | 2013 | 74 | 0.320 |
Why?
|
Metagenome | 3 | 2015 | 176 | 0.320 |
Why?
|
Lipids | 5 | 2024 | 644 | 0.320 |
Why?
|
Dietary Fiber | 3 | 2018 | 123 | 0.320 |
Why?
|
Leucine | 2 | 2013 | 352 | 0.320 |
Why?
|
Lactoferrin | 2 | 2019 | 81 | 0.310 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 1085 | 0.310 |
Why?
|
Dysbiosis | 2 | 2021 | 134 | 0.310 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 4314 | 0.310 |
Why?
|
Dairy Products | 2 | 2019 | 38 | 0.310 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2009 | 317 | 0.300 |
Why?
|
Arm | 3 | 2020 | 147 | 0.290 |
Why?
|
Food Contamination | 1 | 2006 | 22 | 0.290 |
Why?
|
CD4 Lymphocyte Count | 4 | 2014 | 297 | 0.290 |
Why?
|
Cluster Analysis | 4 | 2021 | 1053 | 0.280 |
Why?
|
Urine | 2 | 2018 | 143 | 0.280 |
Why?
|
Africa South of the Sahara | 5 | 2014 | 101 | 0.280 |
Why?
|
Precision Medicine | 1 | 2013 | 1154 | 0.270 |
Why?
|
Single-Blind Method | 5 | 2018 | 409 | 0.260 |
Why?
|
Receptors, Glucocorticoid | 1 | 2006 | 192 | 0.250 |
Why?
|
Environmental Exposure | 2 | 2017 | 288 | 0.250 |
Why?
|
Africa | 4 | 2018 | 142 | 0.250 |
Why?
|
Fish Oils | 2 | 2015 | 88 | 0.250 |
Why?
|
Hydrocortisone | 1 | 2006 | 388 | 0.250 |
Why?
|
Energy Metabolism | 3 | 2020 | 992 | 0.250 |
Why?
|
Cattle | 3 | 2021 | 783 | 0.250 |
Why?
|
Linoleic Acid | 2 | 2022 | 29 | 0.250 |
Why?
|
Docosahexaenoic Acids | 2 | 2015 | 79 | 0.250 |
Why?
|
Sepsis | 2 | 2008 | 652 | 0.240 |
Why?
|
Follow-Up Studies | 10 | 2018 | 14889 | 0.240 |
Why?
|
Hospitalization | 4 | 2021 | 2083 | 0.240 |
Why?
|
Birth Weight | 2 | 2022 | 374 | 0.220 |
Why?
|
Child Health Services | 2 | 2018 | 82 | 0.220 |
Why?
|
Research Design | 3 | 2021 | 1544 | 0.220 |
Why?
|
Severity of Illness Index | 5 | 2018 | 4320 | 0.220 |
Why?
|
Cysteine | 1 | 2024 | 214 | 0.220 |
Why?
|
Adult | 19 | 2024 | 77950 | 0.220 |
Why?
|
Polyomavirus | 2 | 2012 | 30 | 0.220 |
Why?
|
Metadata | 1 | 2022 | 7 | 0.220 |
Why?
|
Bangladesh | 1 | 2022 | 24 | 0.220 |
Why?
|
Religious Missions | 1 | 2002 | 2 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 2594 | 0.210 |
Why?
|
Vitamin A Deficiency | 2 | 2013 | 21 | 0.210 |
Why?
|
Starvation | 1 | 2002 | 27 | 0.210 |
Why?
|
Intention to Treat Analysis | 2 | 2019 | 130 | 0.210 |
Why?
|
Food Handling | 2 | 2019 | 22 | 0.210 |
Why?
|
Maternal Age | 1 | 2022 | 152 | 0.210 |
Why?
|
Delivery of Health Care | 1 | 2009 | 860 | 0.210 |
Why?
|
Antiprotozoal Agents | 1 | 2021 | 40 | 0.200 |
Why?
|
Vaginal Diseases | 1 | 2021 | 26 | 0.200 |
Why?
|
Plants, Genetically Modified | 2 | 2012 | 66 | 0.200 |
Why?
|
Recommended Dietary Allowances | 3 | 2018 | 24 | 0.200 |
Why?
|
Health Status | 3 | 2016 | 590 | 0.200 |
Why?
|
Recurrence | 6 | 2020 | 4758 | 0.200 |
Why?
|
Acute-Phase Proteins | 2 | 2016 | 79 | 0.200 |
Why?
|
Nutritional Sciences | 1 | 2021 | 68 | 0.200 |
Why?
|
Azithromycin | 1 | 2021 | 78 | 0.200 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 2403 | 0.200 |
Why?
|
Adolescent | 11 | 2022 | 31252 | 0.190 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 306 | 0.190 |
Why?
|
Cachexia | 2 | 2023 | 161 | 0.190 |
Why?
|
Genome, Viral | 3 | 2017 | 155 | 0.190 |
Why?
|
Reproducibility of Results | 3 | 2022 | 6009 | 0.190 |
Why?
|
Feasibility Studies | 3 | 2016 | 2292 | 0.190 |
Why?
|
Fluid Therapy | 2 | 2014 | 182 | 0.190 |
Why?
|
Sugars | 1 | 2020 | 15 | 0.180 |
Why?
|
Disclosure | 1 | 2021 | 181 | 0.180 |
Why?
|
Powders | 2 | 2018 | 23 | 0.180 |
Why?
|
Pneumonia | 1 | 2006 | 751 | 0.180 |
Why?
|
Income | 1 | 2020 | 222 | 0.180 |
Why?
|
Bacteriophages | 1 | 2020 | 71 | 0.180 |
Why?
|
Body Weight | 5 | 2016 | 1293 | 0.180 |
Why?
|
Zimbabwe | 1 | 2019 | 10 | 0.170 |
Why?
|
Child Mortality | 2 | 2009 | 21 | 0.170 |
Why?
|
Publishing | 1 | 2021 | 220 | 0.170 |
Why?
|
Drinking Water | 2 | 2022 | 21 | 0.170 |
Why?
|
Food Ingredients | 1 | 2018 | 1 | 0.170 |
Why?
|
Meat | 1 | 2019 | 87 | 0.160 |
Why?
|
World Health Organization | 3 | 2015 | 316 | 0.160 |
Why?
|
Time Factors | 8 | 2018 | 12926 | 0.160 |
Why?
|
Urban Health Services | 1 | 2018 | 37 | 0.160 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 993 | 0.160 |
Why?
|
Rural Health Services | 1 | 2018 | 39 | 0.160 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2018 | 52 | 0.160 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 643 | 0.160 |
Why?
|
Standard of Care | 1 | 2019 | 243 | 0.160 |
Why?
|
Young Adult | 9 | 2021 | 21445 | 0.160 |
Why?
|
Cohort Studies | 6 | 2023 | 9244 | 0.150 |
Why?
|
Viral Load | 2 | 2010 | 493 | 0.150 |
Why?
|
Pediatrics | 2 | 2009 | 1141 | 0.150 |
Why?
|
Diet Records | 3 | 2019 | 77 | 0.150 |
Why?
|
Lipid Metabolism | 2 | 2018 | 483 | 0.150 |
Why?
|
United Nations | 1 | 2017 | 11 | 0.150 |
Why?
|
Regression Analysis | 3 | 2015 | 1546 | 0.150 |
Why?
|
RNA Virus Infections | 1 | 2017 | 8 | 0.150 |
Why?
|
Polyphenols | 1 | 2017 | 29 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8865 | 0.150 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 630 | 0.150 |
Why?
|
RNA Viruses | 1 | 2017 | 43 | 0.150 |
Why?
|
Periodicals as Topic | 1 | 2021 | 338 | 0.150 |
Why?
|
Eicosapentaenoic Acid | 2 | 2015 | 92 | 0.150 |
Why?
|
Patient Discharge | 2 | 2020 | 661 | 0.150 |
Why?
|
Neurotransmitter Agents | 1 | 2017 | 159 | 0.150 |
Why?
|
Water | 1 | 2019 | 361 | 0.140 |
Why?
|
Health Services | 1 | 2017 | 105 | 0.140 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 105 | 0.140 |
Why?
|
Cooking | 2 | 2018 | 66 | 0.140 |
Why?
|
Glycerophospholipids | 1 | 2016 | 7 | 0.140 |
Why?
|
Failure to Thrive | 1 | 2016 | 91 | 0.140 |
Why?
|
Fatty Liver | 1 | 2018 | 235 | 0.140 |
Why?
|
Social Class | 1 | 2018 | 310 | 0.140 |
Why?
|
Soybean Proteins | 1 | 2016 | 20 | 0.140 |
Why?
|
Age Factors | 5 | 2018 | 5377 | 0.140 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2015 | 41 | 0.140 |
Why?
|
Pakistan | 1 | 2016 | 77 | 0.140 |
Why?
|
Emulsifying Agents | 1 | 2015 | 2 | 0.140 |
Why?
|
Swine | 1 | 2020 | 1541 | 0.140 |
Why?
|
Sphingolipids | 1 | 2016 | 38 | 0.140 |
Why?
|
Digestion | 1 | 2016 | 55 | 0.140 |
Why?
|
Viscosity | 1 | 2015 | 47 | 0.140 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 1225 | 0.130 |
Why?
|
Oleic Acid | 1 | 2015 | 20 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 336 | 0.130 |
Why?
|
Twins | 1 | 2015 | 70 | 0.130 |
Why?
|
Twin Studies as Topic | 1 | 2015 | 17 | 0.130 |
Why?
|
DNA Viruses | 1 | 2015 | 48 | 0.130 |
Why?
|
Glutathione | 1 | 2017 | 368 | 0.130 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 265 | 0.130 |
Why?
|
Oils | 1 | 2014 | 9 | 0.130 |
Why?
|
Bile Acids and Salts | 1 | 2017 | 246 | 0.130 |
Why?
|
Infant Formula | 1 | 2015 | 91 | 0.130 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 717 | 0.130 |
Why?
|
Germ-Free Life | 4 | 2016 | 69 | 0.130 |
Why?
|
Logistic Models | 2 | 2012 | 3441 | 0.120 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2014 | 94 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2023 | 1945 | 0.120 |
Why?
|
Cross-Over Studies | 1 | 2016 | 460 | 0.120 |
Why?
|
Immunoglobulin A | 1 | 2015 | 237 | 0.120 |
Why?
|
RNA, Viral | 1 | 2017 | 671 | 0.120 |
Why?
|
Nutritional Support | 1 | 2014 | 80 | 0.120 |
Why?
|
Dysentery, Bacillary | 1 | 2013 | 11 | 0.120 |
Why?
|
Metabolome | 1 | 2016 | 344 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2014 | 100 | 0.120 |
Why?
|
Incidence | 4 | 2015 | 5673 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2016 | 702 | 0.120 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 663 | 0.120 |
Why?
|
Measles | 1 | 2013 | 36 | 0.110 |
Why?
|
Caregivers | 3 | 2018 | 677 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 375 | 0.110 |
Why?
|
Biological Availability | 3 | 2015 | 214 | 0.110 |
Why?
|
Placebos | 1 | 2014 | 437 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2019 | 6100 | 0.110 |
Why?
|
Dietary Sucrose | 1 | 2012 | 42 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2013 | 99 | 0.110 |
Why?
|
Morbidity | 2 | 2014 | 397 | 0.110 |
Why?
|
Plant Roots | 1 | 2012 | 45 | 0.110 |
Why?
|
Reference Values | 2 | 2015 | 1099 | 0.110 |
Why?
|
Lectins, C-Type | 1 | 2013 | 162 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2014 | 234 | 0.100 |
Why?
|
Atrophy | 1 | 2012 | 261 | 0.100 |
Why?
|
Gastritis | 1 | 2015 | 373 | 0.100 |
Why?
|
Biodiversity | 1 | 2012 | 91 | 0.100 |
Why?
|
Prevalence | 5 | 2023 | 3260 | 0.100 |
Why?
|
Sucrose | 2 | 2009 | 64 | 0.100 |
Why?
|
beta Carotene | 1 | 2012 | 76 | 0.100 |
Why?
|
Soybean Oil | 1 | 2011 | 66 | 0.100 |
Why?
|
Polyomavirus Infections | 1 | 2012 | 139 | 0.100 |
Why?
|
Foods, Specialized | 1 | 2011 | 2 | 0.100 |
Why?
|
DNA Methylation | 2 | 2019 | 2669 | 0.100 |
Why?
|
Quality of Life | 3 | 2010 | 4532 | 0.100 |
Why?
|
Phylogeny | 4 | 2017 | 826 | 0.100 |
Why?
|
Pilot Projects | 2 | 2015 | 2803 | 0.100 |
Why?
|
Thinness | 2 | 2008 | 82 | 0.100 |
Why?
|
Colon | 1 | 2015 | 670 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2023 | 37905 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2012 | 329 | 0.100 |
Why?
|
Stavudine | 1 | 2010 | 2 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 4938 | 0.100 |
Why?
|
Nevirapine | 1 | 2010 | 17 | 0.090 |
Why?
|
Lamivudine | 1 | 2010 | 28 | 0.090 |
Why?
|
Disease Progression | 2 | 2014 | 6682 | 0.090 |
Why?
|
Patient Compliance | 1 | 2014 | 667 | 0.090 |
Why?
|
Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2010 | 72 | 0.090 |
Why?
|
Kinetics | 1 | 2013 | 2049 | 0.090 |
Why?
|
Regional Health Planning | 1 | 2009 | 8 | 0.090 |
Why?
|
Overweight | 1 | 2013 | 484 | 0.090 |
Why?
|
Genetics, Medical | 1 | 2010 | 143 | 0.090 |
Why?
|
Glycosaminoglycans | 1 | 2009 | 61 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 5159 | 0.090 |
Why?
|
Transcriptome | 1 | 2018 | 1859 | 0.090 |
Why?
|
Sleep | 1 | 2012 | 413 | 0.090 |
Why?
|
Tropical Climate | 1 | 2009 | 51 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 889 | 0.090 |
Why?
|
Disease Management | 1 | 2014 | 1052 | 0.080 |
Why?
|
Convalescence | 1 | 2008 | 25 | 0.080 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 254 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 4053 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2018 | 7222 | 0.080 |
Why?
|
Genetic Loci | 1 | 2010 | 481 | 0.080 |
Why?
|
Risk | 1 | 2013 | 1972 | 0.080 |
Why?
|
Case Management | 1 | 2008 | 35 | 0.080 |
Why?
|
Liver | 1 | 2018 | 2961 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6207 | 0.080 |
Why?
|
Home Nursing | 2 | 2004 | 25 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 3719 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2010 | 128 | 0.080 |
Why?
|
Iron | 1 | 2011 | 376 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2009 | 298 | 0.080 |
Why?
|
History, 21st Century | 1 | 2009 | 441 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 4971 | 0.080 |
Why?
|
Physician's Role | 1 | 2009 | 238 | 0.070 |
Why?
|
Food Technology | 1 | 2006 | 1 | 0.070 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2006 | 5 | 0.070 |
Why?
|
History, 20th Century | 1 | 2009 | 574 | 0.070 |
Why?
|
Consumer Product Safety | 1 | 2006 | 26 | 0.070 |
Why?
|
Shock, Septic | 1 | 2008 | 181 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 2483 | 0.070 |
Why?
|
Surveys and Questionnaires | 4 | 2011 | 5687 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 446 | 0.070 |
Why?
|
Diet Surveys | 1 | 2006 | 117 | 0.070 |
Why?
|
Minerals | 2 | 2016 | 71 | 0.070 |
Why?
|
Lactobacillus | 1 | 2005 | 58 | 0.070 |
Why?
|
Mice | 6 | 2018 | 34495 | 0.070 |
Why?
|
Nutrition Policy | 2 | 2017 | 111 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2008 | 583 | 0.060 |
Why?
|
Vitamins | 2 | 2016 | 157 | 0.060 |
Why?
|
Geography | 2 | 2017 | 140 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 2315 | 0.060 |
Why?
|
Prognosis | 2 | 2014 | 21713 | 0.060 |
Why?
|
Phytochemicals | 1 | 2024 | 10 | 0.060 |
Why?
|
Chronic Disease | 2 | 2020 | 1819 | 0.060 |
Why?
|
Leukocytes | 1 | 2006 | 422 | 0.060 |
Why?
|
Livestock | 1 | 2023 | 4 | 0.060 |
Why?
|
Bacterial Load | 1 | 2023 | 46 | 0.060 |
Why?
|
Environmental Microbiology | 1 | 2023 | 22 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 1399 | 0.060 |
Why?
|
Carbon Isotopes | 1 | 2004 | 333 | 0.060 |
Why?
|
Antigens, Viral, Tumor | 2 | 2012 | 47 | 0.060 |
Why?
|
Zinc Isotopes | 1 | 2002 | 2 | 0.050 |
Why?
|
Soil | 1 | 2022 | 48 | 0.050 |
Why?
|
Spectrophotometry, Atomic | 1 | 2002 | 14 | 0.050 |
Why?
|
Probiotics | 1 | 2005 | 228 | 0.050 |
Why?
|
United States | 5 | 2021 | 15433 | 0.050 |
Why?
|
Pregnant Women | 1 | 2024 | 162 | 0.050 |
Why?
|
Gambia | 2 | 2012 | 29 | 0.050 |
Why?
|
Hunger | 1 | 2002 | 47 | 0.050 |
Why?
|
Antioxidants | 1 | 2005 | 507 | 0.050 |
Why?
|
Urinalysis | 1 | 2002 | 84 | 0.050 |
Why?
|
Growth and Development | 1 | 2021 | 28 | 0.050 |
Why?
|
Vegetables | 1 | 2024 | 325 | 0.050 |
Why?
|
Carbon | 1 | 2022 | 149 | 0.050 |
Why?
|
Twins, Monozygotic | 2 | 2012 | 129 | 0.050 |
Why?
|
South Sudan | 1 | 2020 | 2 | 0.050 |
Why?
|
Editorial Policies | 1 | 2021 | 87 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2004 | 527 | 0.050 |
Why?
|
Sheep | 1 | 2021 | 258 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2006 | 1620 | 0.050 |
Why?
|
Dried Blood Spot Testing | 1 | 2020 | 21 | 0.050 |
Why?
|
Chickens | 1 | 2021 | 523 | 0.050 |
Why?
|
Microbial Viability | 1 | 2020 | 62 | 0.050 |
Why?
|
Jamaica | 1 | 2019 | 30 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 4744 | 0.050 |
Why?
|
Fermentation | 1 | 2019 | 60 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 52 | 0.040 |
Why?
|
Mammals | 1 | 2021 | 361 | 0.040 |
Why?
|
Health Promotion | 1 | 2024 | 502 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2004 | 1038 | 0.040 |
Why?
|
Base Sequence | 2 | 2017 | 4917 | 0.040 |
Why?
|
Fagaceae | 1 | 2019 | 1 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 6942 | 0.040 |
Why?
|
Poultry | 1 | 2019 | 10 | 0.040 |
Why?
|
West Indies | 1 | 2018 | 8 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2019 | 216 | 0.040 |
Why?
|
Fishes | 1 | 2019 | 44 | 0.040 |
Why?
|
Taste Perception | 1 | 2018 | 4 | 0.040 |
Why?
|
Sudan | 1 | 2018 | 3 | 0.040 |
Why?
|
Equivalence Trials as Topic | 1 | 2018 | 23 | 0.040 |
Why?
|
Forecasting | 1 | 2021 | 694 | 0.040 |
Why?
|
Asia | 1 | 2018 | 142 | 0.040 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2018 | 59 | 0.040 |
Why?
|
Acetylation | 1 | 2019 | 508 | 0.040 |
Why?
|
Epigenomics | 1 | 2019 | 266 | 0.040 |
Why?
|
Seasons | 2 | 2010 | 340 | 0.040 |
Why?
|
Middle Aged | 5 | 2015 | 86204 | 0.040 |
Why?
|
Animal Feed | 1 | 2018 | 81 | 0.040 |
Why?
|
CpG Islands | 1 | 2019 | 633 | 0.040 |
Why?
|
Macaca nemestrina | 1 | 2017 | 16 | 0.040 |
Why?
|
Flavonoids | 1 | 2018 | 188 | 0.040 |
Why?
|
Food-Drug Interactions | 1 | 2017 | 22 | 0.040 |
Why?
|
Patient Satisfaction | 2 | 2015 | 915 | 0.040 |
Why?
|
Anthelmintics | 1 | 2016 | 69 | 0.040 |
Why?
|
Whey | 1 | 2016 | 1 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 543 | 0.040 |
Why?
|
Mozambique | 1 | 2016 | 16 | 0.040 |
Why?
|
Clostridiales | 1 | 2016 | 14 | 0.040 |
Why?
|
Parasitic Diseases | 1 | 2017 | 65 | 0.040 |
Why?
|
United Kingdom | 1 | 2016 | 257 | 0.030 |
Why?
|
Child Health | 1 | 2016 | 54 | 0.030 |
Why?
|
Aged | 3 | 2012 | 70117 | 0.030 |
Why?
|
Contig Mapping | 1 | 2015 | 61 | 0.030 |
Why?
|
alpha-Linolenic Acid | 1 | 2015 | 17 | 0.030 |
Why?
|
Bone Development | 1 | 2016 | 83 | 0.030 |
Why?
|
Bifidobacterium | 1 | 2016 | 64 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 2015 | 108 | 0.030 |
Why?
|
Flatulence | 1 | 2015 | 6 | 0.030 |
Why?
|
Taste | 1 | 2015 | 50 | 0.030 |
Why?
|
Microbial Consortia | 1 | 2015 | 7 | 0.030 |
Why?
|
6-Phytase | 1 | 2015 | 3 | 0.030 |
Why?
|
Drug Interactions | 1 | 2017 | 553 | 0.030 |
Why?
|
Femur | 1 | 2016 | 158 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2017 | 467 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 6089 | 0.030 |
Why?
|
Arachidonic Acid | 1 | 2015 | 118 | 0.030 |
Why?
|
Body Size | 1 | 2015 | 70 | 0.030 |
Why?
|
Cytokines | 1 | 2004 | 2809 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 844 | 0.030 |
Why?
|
Hydrolysis | 1 | 2015 | 227 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2017 | 717 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2015 | 149 | 0.030 |
Why?
|
Phospholipids | 1 | 2015 | 177 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2015 | 445 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2014 | 111 | 0.030 |
Why?
|
Survivors | 1 | 2019 | 1031 | 0.030 |
Why?
|
Community Health Services | 1 | 2015 | 126 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 651 | 0.030 |
Why?
|
Pancreatitis-Associated Proteins | 1 | 2013 | 32 | 0.030 |
Why?
|
Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
Motor Skills | 1 | 2013 | 107 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 2013 | 74 | 0.030 |
Why?
|
Qualitative Research | 1 | 2015 | 556 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 289 | 0.030 |
Why?
|
Venezuela | 1 | 2012 | 13 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 4892 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2012 | 354 | 0.030 |
Why?
|
Twins, Dizygotic | 1 | 2012 | 49 | 0.030 |
Why?
|
Models, Animal | 1 | 2015 | 664 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 187 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2012 | 158 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2015 | 677 | 0.020 |
Why?
|
Family | 1 | 2015 | 736 | 0.020 |
Why?
|
Puerto Rico | 1 | 2011 | 65 | 0.020 |
Why?
|
Fertilization | 1 | 2010 | 56 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2010 | 29902 | 0.020 |
Why?
|
Focus Groups | 1 | 2011 | 256 | 0.020 |
Why?
|
DNA, Viral | 1 | 2012 | 694 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 1271 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2012 | 613 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 3154 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 2738 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 419 | 0.020 |
Why?
|
Health Personnel | 1 | 2015 | 625 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2012 | 584 | 0.020 |
Why?
|
Educational Status | 1 | 2011 | 397 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 497 | 0.020 |
Why?
|
Program Evaluation | 1 | 2011 | 597 | 0.020 |
Why?
|
Fish Products | 1 | 2008 | 3 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2012 | 834 | 0.020 |
Why?
|
South Africa | 1 | 2008 | 92 | 0.020 |
Why?
|
Population Surveillance | 1 | 2011 | 627 | 0.020 |
Why?
|
Cough | 1 | 2008 | 116 | 0.020 |
Why?
|
Mothers | 1 | 2011 | 410 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 2291 | 0.020 |
Why?
|
Nitriles | 1 | 2011 | 906 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2005 | 33 | 0.020 |
Why?
|
Riboflavin | 1 | 2005 | 26 | 0.020 |
Why?
|
Selenium | 1 | 2005 | 47 | 0.020 |
Why?
|
Vitamin E | 1 | 2005 | 136 | 0.020 |
Why?
|
Hemoglobins | 1 | 2006 | 477 | 0.020 |
Why?
|
Databases, Factual | 1 | 2011 | 2218 | 0.020 |
Why?
|
Acetylcysteine | 1 | 2005 | 143 | 0.020 |
Why?
|
Tropical Medicine | 1 | 2005 | 105 | 0.020 |
Why?
|
Risk Assessment | 1 | 2016 | 6869 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 2086 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2004 | 144 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 6295 | 0.010 |
Why?
|
Mental Recall | 1 | 2004 | 171 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 10001 | 0.010 |
Why?
|
Tuberculosis | 1 | 2008 | 548 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 9180 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 3869 | 0.010 |
Why?
|